• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年 2 型糖尿病胰岛素治疗患者的脂肪增生

Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes.

作者信息

Gentile Sandro, Guarino Giuseppina, Della Corte Teresa, Marino Giampiero, Fusco Alessandra, Corigliano Gerardo, Colarusso Sara, Piscopo Marco, Improta Maria Rosaria, Corigliano Marco, Martedi Emilia, Oliva Domenica, Russo Viviana, Simonetti Rosa, Satta Ersilia, Romano Carmine, Vaia Sebastiano, Strollo Felice

机构信息

Department of Internal Medicine, Campania University "Luigi Vanvitelli", Naples, Italy.

Diabetes Unit AID Stabia, Nefrocenter Research and Nyx Start-Up, Naples, Italy.

出版信息

Diabetes Ther. 2021 Jan;12(1):107-119. doi: 10.1007/s13300-020-00954-3. Epub 2020 Nov 21.

DOI:10.1007/s13300-020-00954-3
PMID:33219928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7843727/
Abstract

BACKGROUND

The number of older adults with insulin-treated diabetes mellitus (DM) is steadily increasing worldwide. Errors in the insulin injection technique can lead to skin lipohypertrophy (LH), which is the accumulation of fat cells and fibrin in the subcutaneous tissue. While lipohypertrophic lesions/nodules (LHs) due to incorrect insulin injection techniques are very common, they are often flat and hardly visible and thus require thorough deep palpation examination and ultrasonography (US) for detection. Detection is crucial because such lesions may eventually result in poor diabetes control due to their association with unpredictable insulin release patterns. Skin undergoes fundamental structural changes with aging, possibly increasing the risk for LH. We have therefore investigated the effect of age on the prevalence of LHs and on factors potentially associated with such lesions.

METHODS

A total of 1227 insulin-treated outpatients with type 2 DM (T2DM) referred to our diabetes centers were consecutively enrolled in the study. These patients underwent a thorough clinical and US evaluation of the skin at injection sites, as previously described, with up to 95% concordance betweenthe clinical and US screening techniques. Of these 1227 patients, 718 (59%) had LH (LH+) and 509 (41%) were LH-free (LH-). These patients were then assigned to two age class groups (≤ 65 years and > 65 years), and several clinical features, diabetes complication rates, and injection habits were investigated.

RESULTS

Comparison of the two age subgroups revealed that 396 (48%) and 322 (79%) patients in the younger and older groups, respectively, had LHs (p < 0.001). Compared to the younger subgroup, the older subgroup displayed a higher LH rate in the abdomen (52.9 vs. 38.3%; p < 0.01) and a lower rate in the arms (25.4 vs. 35.8%; p < 0.05), thighs (26.7 vs. 33.4%; p < 0.05), and buttocks (4.9 vs. 26.2%; p < 0.01). In older subjects, the most relevant parameters were: habit of injecting insulin into LH nodules (56 vs. 47% [younger subjects]; p < 0.01), rate of post-injection leakage of insulin from injection site (drop-leaking rate; 47 vs. 39% [younger subjects]; p < 0.05), and rate of painful injections (5 vs. 16% [younger subjects]; p < 0.001). Multivariate analysis showed a stronger association between LH and poor habits, as well as between several clinical parameters, among which the most relevant were hypoglycemic events and glycemic variability.

DISCUSSION

The higher rate of post-injection drop-leaking and pain-free injections might find an explanation in skin changes typically observed in older adults, including lower thickness, vascularity and elasticity, and a more prominent fibrous texture, all of which negatively affect tissue distensibility. Consequently, in addition to the well-known association between aging skin impaired drug absorption rate, aging skin displays a progressively decreasing ability to accommodate large volumes of insulin-containing fluid.

CONCLUSIONS

The strong association between LH rate and hypoglycemic events plus glycemic variability suggests the need (1) to take specific actions to prevent and control the high risk of acute cardiovascular events expected to occur in older subjects in the case of hypoglycemic events, and (2) to identify suitable strategies to fulfill the difficult task of performing effective educational programs specifically targeted to the elderly.

TRIAL REGISTRATION

Trial registration number 172-11:12.2019, Scientific and Ethical Committee of Campania University "Luigi Vanvitelli", Naples, Italy).

摘要

背景

在全球范围内,接受胰岛素治疗的老年糖尿病患者数量正在稳步增加。胰岛素注射技术错误可导致皮肤脂肪增生(LH),即皮下组织中脂肪细胞和纤维蛋白的堆积。虽然因胰岛素注射技术不正确导致的脂肪增生性病变/结节(LH)非常常见,但它们通常很扁平,几乎不可见,因此需要进行彻底的深部触诊检查和超声检查(US)来检测。检测至关重要,因为此类病变可能最终导致糖尿病控制不佳,原因是它们与不可预测的胰岛素释放模式有关。随着年龄增长,皮肤会发生根本性的结构变化,这可能会增加发生LH的风险。因此,我们研究了年龄对LH患病率以及与此类病变潜在相关因素的影响。

方法

共有1227名转诊至我们糖尿病中心的接受胰岛素治疗的2型糖尿病(T2DM)门诊患者连续纳入本研究。如前所述,这些患者对注射部位皮肤进行了全面的临床和超声评估,临床和超声筛查技术的一致性高达95%。在这1227名患者中,718名(59%)有LH(LH+),509名(41%)无LH(LH-)。然后将这些患者分为两个年龄组(≤65岁和>65岁),并调查了几个临床特征、糖尿病并发症发生率和注射习惯。

结果

两个年龄亚组的比较显示,较年轻组和较年长组分别有396名(48%)和322名(79%)患者有LH(p<0.001)。与较年轻亚组相比,较年长亚组在腹部的LH发生率较高(52.9%对38.3%;p<0.01),而在手臂(25.4%对35.8%;p<0.05)、大腿(26.7%对33.4%;p<0.05)和臀部(4.9%对26.2%;p<0.01)的发生率较低。在老年受试者中,最相关的参数为:将胰岛素注射到LH结节中的习惯(56%对47%[较年轻受试者];p<0.01)、胰岛素从注射部位注射后渗漏率(滴漏率;47%对39%[较年轻受试者];p<0.05)以及疼痛性注射率(5%对16%[较年轻受试者];p<0.001)。多变量分析显示LH与不良习惯以及几个临床参数之间存在更强的关联,其中最相关的是低血糖事件和血糖变异性。

讨论

注射后滴漏率较高和无痛注射现象可能可以用老年人典型的皮肤变化来解释,包括厚度、血管分布和弹性降低,以及纤维质地更明显,所有这些都会对组织扩张性产生负面影响。因此,除了众所周知的老化皮肤与药物吸收速率受损之间的关联外,老化皮肤容纳大量含胰岛素液体的能力也在逐渐下降。

结论

LH发生率与低血糖事件及血糖变异性之间的密切关联表明需要:(1)采取具体行动预防和控制老年受试者在发生低血糖事件时预期会发生的急性心血管事件的高风险;(2)确定合适的策略,以完成针对老年人开展有效教育项目这项艰巨任务。

试验注册

试验注册号172 - 11:12.2019,意大利那不勒斯坎帕尼亚大学“路易吉·万维泰利”科学与伦理委员会)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/7843727/0321043b25f6/13300_2020_954_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/7843727/0321043b25f6/13300_2020_954_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/7843727/0321043b25f6/13300_2020_954_Fig1_HTML.jpg

相似文献

1
Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes.老年 2 型糖尿病胰岛素治疗患者的脂肪增生
Diabetes Ther. 2021 Jan;12(1):107-119. doi: 10.1007/s13300-020-00954-3. Epub 2020 Nov 21.
2
Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern Italy.2型糖尿病中胰岛素诱导的皮肤脂肪增生:意大利南部的一项多中心区域调查
Diabetes Ther. 2020 Sep;11(9):2001-2017. doi: 10.1007/s13300-020-00876-0. Epub 2020 Jul 18.
3
Role of Structured Education in Reducing Lypodistrophy and its Metabolic Complications in Insulin-Treated People with Type 2 Diabetes: A Randomized Multicenter Case-Control Study.结构化教育在降低2型糖尿病胰岛素治疗患者脂肪营养不良及其代谢并发症中的作用:一项随机多中心病例对照研究
Diabetes Ther. 2021 May;12(5):1379-1398. doi: 10.1007/s13300-021-01006-0. Epub 2021 Mar 18.
4
Errors in insulin treatment management and risk of lipohypertrophy.胰岛素治疗管理中的错误与脂肪肥厚风险。
Acta Diabetol. 2018 Jan;55(1):67-73. doi: 10.1007/s00592-017-1066-y. Epub 2017 Nov 2.
5
Why Do So Many People with Type 2 Diabetes Who Take Insulin Have Lipohypertrophy? Fate or Educational Deficiencies?为什么这么多使用胰岛素的2型糖尿病患者会出现脂肪增生?是命运还是教育缺失?
Diabetes Ther. 2023 Jan;14(1):179-191. doi: 10.1007/s13300-022-01341-w. Epub 2022 Dec 6.
6
Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus.胰岛素治疗的2型糖尿病患者中脂肪增生的患病率及相关危险因素
Int J Endocrinol Metab. 2015 Apr 30;13(2):e20776. doi: 10.5812/ijem.20776. eCollection 2015 Apr.
7
Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes.胰岛素注射和输注方案对糖尿病儿童及成人脂肪增生和血糖控制的影响
Diabetes Ther. 2019 Feb;10(1):259-267. doi: 10.1007/s13300-018-0561-7. Epub 2019 Jan 8.
8
Clinical Implications of Lipohypertrophy Among People with Type 1 Diabetes in India.印度 1 型糖尿病患者脂肪肥厚的临床意义。
Diabetes Technol Ther. 2018 Jul;20(7):483-491. doi: 10.1089/dia.2018.0074. Epub 2018 Jun 22.
9
Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy.1 型糖尿病患者不同程度脂肪肥厚者的抑郁、治疗满意度和注射行为差异。
J Clin Nurs. 2017 Dec;26(23-24):4583-4596. doi: 10.1111/jocn.13801. Epub 2017 May 31.
10
The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study.胰岛素注射致脂肪增生的经济负担。教育的作用:ISTERP-3 研究。
Adv Ther. 2022 May;39(5):2192-2207. doi: 10.1007/s12325-022-02105-5. Epub 2022 Mar 19.

引用本文的文献

1
Determinants of Glycemic Control in Thai Adults with Insulin-Treated Type 2 Diabetes Mellitus: A Cross-Sectional Study.胰岛素治疗的泰国成年2型糖尿病患者血糖控制的决定因素:一项横断面研究。
Patient Prefer Adherence. 2025 Jul 5;19:1909-1922. doi: 10.2147/PPA.S521692. eCollection 2025.
2
The Distinct Ultrasound Characteristics and Prognostic Features of Insulin-Induced Lipohypertrophy: A Systematic Review.胰岛素诱导性脂肪增生的独特超声特征及预后特征:一项系统评价
Diabetes Metab Syndr Obes. 2025 Mar 29;18:941-954. doi: 10.2147/DMSO.S413623. eCollection 2025.
3
Premixed insulin: Advantages, disadvantages, and future.

本文引用的文献

1
Self-management education may improve blood pressure in people with type 2 diabetes. A randomized controlled clinical trial.自我管理教育可能改善 2 型糖尿病患者的血压。一项随机对照临床试验。
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1973-1979. doi: 10.1016/j.numecd.2020.06.023. Epub 2020 Jul 2.
2
Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern Italy.2型糖尿病中胰岛素诱导的皮肤脂肪增生:意大利南部的一项多中心区域调查
Diabetes Ther. 2020 Sep;11(9):2001-2017. doi: 10.1007/s13300-020-00876-0. Epub 2020 Jul 18.
3
The Injection Technique Factor: What You Don't Know or Teach Can Make a Difference.
预混胰岛素:优点、缺点及未来发展
World J Diabetes. 2025 Mar 15;16(3):102526. doi: 10.4239/wjd.v16.i3.102526.
4
Insulin-Induced Severe Lipohypertrophy.胰岛素诱导的严重脂肪增生
AACE Clin Case Rep. 2024 Mar 19;10(5):214-215. doi: 10.1016/j.aace.2024.03.005. eCollection 2024 Sep-Oct.
5
Unveiling Diabetes: Categories, Genetics, Diagnostics, Treatments, and Future Horizons.揭示糖尿病:分类、遗传学、诊断、治疗和未来前景。
Curr Diabetes Rev. 2024;20(4):e180823219972. doi: 10.2174/1573399820666230818092958.
6
Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society.脂肪肥厚与胰岛素:糖尿病技术学会的最新更新。
J Diabetes Sci Technol. 2023 Nov;17(6):1711-1721. doi: 10.1177/19322968231187661. Epub 2023 Aug 9.
7
Prevalence of Lipohypertrophy and its Associations in Insulin-Treated Diabetic Patients.胰岛素治疗的糖尿病患者中脂肪增生的患病率及其关联
Pak J Med Sci. 2023 Jan-Feb;39(1):209-213. doi: 10.12669/pjms.39.1.6134.
8
The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study.胰岛素注射致脂肪增生的经济负担。教育的作用:ISTERP-3 研究。
Adv Ther. 2022 May;39(5):2192-2207. doi: 10.1007/s12325-022-02105-5. Epub 2022 Mar 19.
9
Identification of the Inappropriate Clinical Actions (DON'T) to Improve the Management of Patients with Type 2 Diabetes Failing Basal Insulin Supported Oral Treatment: Results of Survey for a Panel of Diabetes Specialists in Italy.识别不恰当的临床行为(“不该做的事”)以改善基础胰岛素联合口服治疗效果不佳的2型糖尿病患者的管理:意大利糖尿病专家小组调查结果
Diabetes Ther. 2021 Oct;12(10):2645-2661. doi: 10.1007/s13300-021-01137-4. Epub 2021 Aug 20.
10
The Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study.基于强化结构化教育的最佳胰岛素注射实践康复方案的持久性:ISTERP-2研究
Diabetes Ther. 2021 Sep;12(9):2557-2569. doi: 10.1007/s13300-021-01108-9. Epub 2021 Aug 12.
注射技术因素:你所不知道或未传授的内容可能会产生影响。
Clin Diabetes. 2019 Jul;37(3):227-233. doi: 10.2337/cd18-0076.
4
Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach.血液透析糖尿病患者的胰岛素相关脂肪增生:一项多中心观察性研究及方法学探讨
Diabetes Ther. 2019 Aug;10(4):1423-1433. doi: 10.1007/s13300-019-0650-2. Epub 2019 Jun 20.
5
Why are so huge differences reported in the occurrence rate of skin lipohypertrophy? Does it depend on method defects or on lack of interest?为什么皮肤脂肪增生的发生率报告存在如此巨大的差异?这是取决于方法缺陷还是缺乏关注?
Diabetes Metab Syndr. 2019 Jan-Feb;13(1):682-686. doi: 10.1016/j.dsx.2018.11.042. Epub 2018 Nov 16.
6
Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial.血糖波动与退伍军人事务部糖尿病试验中的心血管风险。
Diabetes Care. 2018 Oct;41(10):2187-2194. doi: 10.2337/dc18-0548. Epub 2018 Aug 6.
7
Cost saving effects of a short-term educational intervention entailing lower hypoglycaemic event rates in people with type 1 diabetes and lipo-hypertrophy.一项短期教育干预措施在1型糖尿病患者中降低低血糖事件发生率及脂肪增生的成本节约效果。
Diabetes Res Clin Pract. 2018 Sep;143:320-321. doi: 10.1016/j.diabres.2018.07.030. Epub 2018 Aug 1.
8
Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study.2 型糖尿病老年患者严重低血糖、轻度认知障碍、痴呆和脑容量:动脉粥样硬化风险社区(ARIC)队列研究。
Diabetologia. 2018 Sep;61(9):1956-1965. doi: 10.1007/s00125-018-4668-1. Epub 2018 Jun 30.
9
An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France.一项针对糖尿病性脂肪营养不良的有效干预措施:法国一项随机、对照、前瞻性多中心研究的结果。
Diabetes Technol Ther. 2017 Nov;19(11):623-632. doi: 10.1089/dia.2017.0165. Epub 2017 Oct 23.
10
UK lipohypertrophy interventional study.英国脂肪增生干预研究。
Diabetes Res Clin Pract. 2017 Apr;126:248-253. doi: 10.1016/j.diabres.2017.01.020. Epub 2017 Mar 2.